Kiniksa Pharmaceuticals Ltd. (KNSA)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1. 2,920,023 $28,295 0.6%
2.
Baker Bros. Advisors

Julian Baker And Felix Baker

2,799,577 $27,128 0.15%
3. 1,375,000 $13,324 +8% 0.1%
4.
Great Point Partners

Jeffrey Jay And David Kroin

1,204,028 $11,667 +8% 2.79%
5.
Opaleye Management

James A. Silverman

814,250 $7,890 -27% 3.55%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$19.24 235,019 Large Shareholder, Other 843,352 2018-05-29 Filing
$20.91 25,000 Large Shareholder, Other 608,333 2018-05-29 Filing
$19.81 250,000 Large Shareholder, Other 583,333 2018-05-29 Filing
$18.00 333,333 Large Shareholder, Other 333,333 2018-05-29 Filing
$18.00 69,444 Large Shareholder 900,443 2018-05-29 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$23.07 1,137 Officer, Director 83,336 2021-02-10 Filing
$23.06 1,600 Officer, Director 0 2021-02-10 Filing
$23.08 23,569 Officer, Director 84,473 2021-02-09 Filing
$23.00 4,528 Officer, Director 108,042 2021-02-08 Filing
$23.04 20,401 Officer, Director 0 2021-02-09 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 35,490 $343,898 0%
2. 16,940 $164,149 0%
3. 9,496 $91,997 0.05%
4. 3,535,357 $34,259 0%
5. 3,531,802 $34,223 0.04%
News See All